IMW 2019 | ASCT: time to move on?

Ola Landgren

Ola Landgren, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, explains why he thinks autologous stem-cell transplantation will not remain the standard of care in myeloma in five years. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  
Similar topics